CyGenica logo

CyGenica

Enabling SAFE, targeted and affordable intracellular delivery of therapeutics for cancer and rare diseases

8 employees · est. 2017 · Cork, Ireland

VS
Rampart Bioscience logo

Rampart Bioscience

Leading a new era of effective, safe and accessible gene medicines.

28 employees · est. 2019 · Monrovia, United States

CyGenica is the older company (2017 vs 2019); Rampart Bioscience is the larger of the two.

Side-by-Side Comparison

CyGenica Rampart Bioscience
Founded
2017 older 2019
Headquarters
Cork, Ireland Monrovia, United States
Employees
8 28 larger
Industry
Biotechnology Biopharma, Biotechnology, Health and Wellness
Funding Stage
Seed Series A
Total Funding
$1.40M $125.00M
Funding Rounds
1 2
Services
Not tracked yet Development of Novel DNA-Based Medicines, Research in Gene Delivery and Protein Sciences, Non-Viral DNA Delivery Systems
Target Customers
Not tracked yet Patients with Genetically Driven Diseases, Healthcare Providers Seeking Advanced Therapies
Taxonomy
Intracellular Delivery, Therapeutics, Non-viral Platform, Gene Therapy, Cancer Treatment, Rare Diseases, Drug Delivery System, Genome Editing, Pharmaceutical Industry, In Vitro, In Vivo, Non-toxic Platform, Patient Outcomes Gene Medicines, Genetically Driven Diseases, Gene Delivery, Protein Sciences, Clinical Translation, Non-viral DNA Delivery, Therapeutic Optimization, Potency Enhancement, Durability Of Treatment, Redosability, Safety In Gene Therapies, Proprietary Development Platforms, Non-viral Therapeutics, Biotechnology Innovation, Disease Treatment Reshaping
Website
cygenica.com rampartbio.com
CyGenica logo

About CyGenica

CyGenica is a biotechnology startup based in Ireland, founded in 2017. The company's mission, as reflected in their slogan "Enabling SAFE, targeted and affordable intracellular delivery of therapeutics for cancer and rare diseases," is to develop non-viral, non-toxic delivery solutions for drugs, ge...

Rampart Bioscience logo

About Rampart Bioscience

Rampart Bioscience, founded in 2019, is pioneering advancements in the Biopharma and Biotechnology industries. Based in the United States, the company aims to lead a new era of effective, safe, and accessible gene medicines, targeting patients with genetically driven diseases. Its innovative approac...

We will tell you when either one moves

BounceWatch watches CyGenica and Rampart Bioscience for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CyGenica and Rampart Bioscience — by email.

Frequently Asked Questions

CyGenica — Enabling SAFE, targeted and affordable intracellular delivery of therapeutics for cancer and rare diseases. Rampart Bioscience — Leading a new era of effective, safe and accessible gene medicines.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CyGenica has raised $1.40M while Rampart Bioscience has raised $125.00M.
CyGenica and Rampart Bioscience operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CyGenica with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CyGenica on 11 Sep 2024, and Rampart Bioscience on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes